Contents · 44 / 58
1. Using a watchlist
2. Screeners and saved screens
3. Charts and indicators
4. Economic Intelligence
5. Research workspaces
6. Compare exact listings
7. Read research classifications
8. Use Company Intelligence
9. Understand corporate actions
10. Read insider activity
11. Read news coverage and title analysis
12. Read persisted AI briefings
13. Review decision-signal evidence
14. Read forecast calibration
15. Use Official Data
16. Read stock factsheets
17. Track dividends
18. Use sector analytics
19. Read the Results dashboard
20. Track disclosed investor holdings
21. Screen forensic and distress flags
22. Rank listings in Factor Lab
23. Study session gaps
24. Use the Research Intelligence hub
25. Review company filings pages
26. Read Machine Learning Insights and Factor Attribution
27. Download PDF reports
28. Use XMarketRadar Radar
29. Read Radar Unusual Activity
30. Use the Economic Calendar
31. Read Market Mood Indicators
32. Use the Fundamental Market Monitor
33. Find Statistical Peers
34. Read Beta and the Market Model
35. Read Sector and Size Neutral Factors
36. Test formulas in Alpha Lab
37. Analyse Pairs Trading and Cointegration
38. Conduct Corporate Event Studies
39. Use the Financial Planning and Risk Lab
40. Plan Goals with Mutual Funds
41. Track Portfolio Dividend Income
42. Search Historical Chart Analogs
43. Review Corporate Capital Events
44. Inspect Public-Official Transaction Disclosures
45. Navigate the Research Document Vault
46. Build reports in XMarket Studio
47. Apply Multi-Factor Value Investing Lenses
48. Read the Radar ML shortlist
49. Read the macro charts
50. Browse the market datasets
51. Read the News hub
52. Read Why it moved
53. Read the SWOT tab
54. Read the X-Radar Scorecard
55. Use the Returns Tracker
56. Read US analyst ratings
57. Use the Portfolio Action Center
58. Use the Portfolio Calendar
Research
Intermediate
44 / 58
Inspect Public-Official Transaction Disclosures
Updated 31 October 2026 · 2 min read · 14 Contents
Mark complete
Plain-language meaning
Public-Official Transactions lists the delayed, legally required transaction disclosures filed by US elected officials and executive-branch officials.
Why it is useful #
It gives research visibility into reported purchases and sales by public officials, with their filing lag and value range, in one place.
Where it appears and the workflow #
Open Public-Official Transactions from Official Data (/Research/PublicOfficialTransactions). Filter by authority — all, House, Senate or the Office of Government Ethics — and page through results (up to 100 rows a page).
Calculation or source #
Rows are stored disclosures with transaction date, filing date and disclosed value bracket. Display depends on the data being cleared for use.
Prerequisites, inputs, period and unit #
Values are statutory ranges, such as $1,001–$15,000, not exact amounts.
Worked example #
Illustrative only: a purchase in the $15,001–$50,000 range with a transaction date of 12 May and a filing date of 28 May was disclosed 16 days after the trade.
What high and low mean #
A higher bracket means a larger reported transaction range; counts describe disclosure frequency, not intent.
Positive, negative and zero #
Purchases and sales are labelled by type. Unstated fields stay unavailable rather than zero.
Unavailable values #
While the data is under rights review, the whole page shows as unavailable. Transactions outside the covered disclosure regimes cannot be inferred.
Limitations and common mistakes #
Disclosures arrive with statutory delays, wide value ranges and exemptions, and can cover spouses or dependants.
Market-specific differences #
The coverage is US federal disclosure regimes; other countries' rules are not represented.
Related terms #
Related concepts include SEC, EDGAR and insider activity. Read Read insider activity for company-insider filings.
Suggested next steps #
Filter to one authority, record the median filing lag on the first page, and explain why the value range limits any conclusion.
Educational use only #
This guide explains descriptive research evidence. It is not investment advice, a price prediction, a recommendation, a claim of predictive accuracy, or an instruction to buy, sell, rebalance or place an order.
Related terms
Related guides
Next guide
